Advertisement
Screener

Nkarta, Inc. (NKTX) Number of Reportable Segments

1.4 / 5 stars · 10/37 Roast Me

Nkarta, Inc. Number of Reportable Segments

Nkarta, Inc. (NKTX) reported Number of Reportable Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfReportableSegments · last filed 2026-08-10

  • Nkarta, Inc. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
  • Nkarta, Inc. number of reportable segments for the quarter ending 2025-03-31 was 1.00 Segment.
  • Nkarta, Inc. number of reportable segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
  • Nkarta, Inc. number of reportable segments for fiscal 2024 was 1.00 Segment.
Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-06-301.00 Segment
10-Q · filed 2026-08-10
2026-03-311.00 Segment
10-Q · filed 2026-05-12
2025-12-311.00 Segment
10-K · filed 2026-03-25
2025-09-301.00 Segment
10-Q · filed 2025-11-10
2025-06-301.00 Segment
10-Q · filed 2025-08-12
2025-03-311.00 Segment
10-Q · filed 2025-05-14
2024-12-311.00 Segment
10-K · filed 2025-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
PepGen Inc. (PEPG)United States$0.186B-1.73
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51